Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: Lab Invest. 2011 Aug 1;91(10):1540–1550. doi: 10.1038/labinvest.2011.108

Figure 2.

Figure 2

Pathology of lung, spleen, liver, and kidneys. A. Lung pathology of untreated vs. pristane-treated C57BL/6 (B6) and BALB/c mice. Representative gross pathology and H&E stained tissue sections of lungs from untreated (top) or pristane-treated (bottom) C57BL/6 (left) and BALB/c (right) mice are shown (200x magnification). BALB/c (n=7) and C57BL/6 (n=24) mice received a single 0.5ml i.p. injection of pristane. B. Histology of the spleen, liver and kidneys from pristane-treated and untreated control C57BL/6 mice. Tissues were harvested from mice that received an i.p. injection of pristane 14 days earlier or left untreated (200x magnification, H&E).